Medicinal Cannabis Market: Global Industry Research Report 2020-2027 | Envisage Research

Medicinal Cannabis Market - By Product Type (Buds, Oils, Tinctures), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), By Application (Pain Management, Neuropathic Pain, Cancer Pain, Others, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical) and By Region (North America, Europe, Asia Pacific, Middle East and Africa, Latin America, ROW) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 181

Status: Published

Report Code: EMR100345

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2027. The market was valued at 14000 Million in 2020 and is growing at a CAGR of 25.16% in the forecast period of 2021 to 2027 is expected to reach USD 67,354.01 million by 2027. Increased medical use and legalization of cannabis is acting as a driver for the medical cannabis market. Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes. Medical cannabis is cannabis and cannabinoids that are prescribed by physicians for their patients.

The Marijuana contains over 500 different substances primary psychoactive component includes tetrahydrocannabinol. Medical cannabis is obtained from the Cannabis Sativa and Cannabis Indica plants. It contains three major active compounds namely, Cannabidiol (CBD), Tetrahydrocannabinol (THC) and Cannabinol (CBN). As compared to recreational cannabis, medical cannabis has a lower amount of THC and a higher count of CBD which provides therapeutic advantages to patients and aids in retaining anti-psychotic effects. This plant-based drug is gradually gaining acceptance in the pharmaceutical industry as it helps in improving the mood, immune function and vascular health. It is now used for curing anxiety, nausea, depression, chronic pain and side effects of multiple sclerosis, epilepsy, PTSD and Parkinson’s disease. It is prescribed in different forms like vapor, oral capsules, topical solutions, creams and balms.

Analyst commentary

The growth of the global medical marijuana is primarily driven by increasing conditions that require medical marijuana for the treatment, rising geriatric population in need of treatment for chronic diseases, awareness programs conducted by public and private associations, and growing number of medical marijuana clubs, which promote the quality associated with medical marijuana. However, manufacturers on a global level are engaged in developing products that should get recognition in order to be in use for a greater population. The legalization of medical marijuana in developing countries is expected to drive the demand for medical marijuana as an alternative for traditional medicines. It makes the medical marijuana industry more accessible for the new players with fragmented company profiles Long-term regular use of cannabis may increase your risk for severe nausea and vomiting (cannabinoid hyperemesis syndrome, or CHS).

Cannabis can interact with many other medicines. It can be dangerous if the use is for medicines that make you sleepy, control your mood or make you high. These include sedatives, anxiety drugs, antidepressants, and opioids. It can also be dangerous to use cannabis with alcohol, tobacco, and illegal drugs. Cannabis can affect your blood pressure; the use should be cautious if you take in form of medicine. It also increases the chance of bleeding if you're on blood thinners.
People who have CHS may feel very thirsty and have belly pain and diarrhoea. They may vomit more than 20 times a day. Bouts of vomiting may last more than 24 hours.

The benefits of cannabis have drawn the attention of several investors across the world. The increasing emphasis on the development of newer products, infused with cannabis will encourage several competitors to deviate from their core business and invest in medical cannabis. The legalization of cannabis in major countries across the world will emerge in favour of medical cannabis market growth.

Segmentation

The global medical cannabis market is bifurcated by product form, by-product, application, and end-user. The market, based on product form, is divided into powders, solids, ointments and creams, oils, and others. The powder segment is predicted to grow rapidly as the powder dissolves easily in any liquid; this greatly increases the chances of patients consuming their marijuana products for medicinal purposes. The easy consumption of powdered products will considerably stimulate market growth.
On the basis of distribution channels, the global medical cannabis market is bifurcated into retail pharmacies, online stores, and others. The retail pharmacy segment is expected to have the largest market share, with most retailers and pharmacies supplying cannabis worldwide.
Medical cannabis market is segmented of the basis of species, derivatives, application and route of administration. these segments will analyse segments in the industries, based on species, the medical cannabis market is segmented into cannabis Indica, sativa and hybrid

By Product Type, the market is segmented into Buds, Oils, Tinctures.
By Distribution Channel, the Market is segmented into hospital pharmacies, retail, Pharmacies, online stores.
By Application, the market is segmented into Pain Management, Neuropathic Pain, Cancer Pain, Others like Muscle Spasms, Nausea, Anorexia, Seizures, Others
By Route of Administration, the market is segmented into Inhalation, Oral, Topical.

Key player

Canopy Growth Corporation-Spectrum Therapeutics is focused on developing and researching clinically-ready, whole-plant cannabis drug formulations and dose delivery systems. The ultimate goal is to validate diversified treatment options for Canadians and for patients and consumers in other jurisdictions where treatment with cannabis is federally legal.

Tilray- A global pioneer in cannabis production, research, cultivation and distribution, announced its wholly-owned subsidiary Tilray Portugal Unipessoal Lda has partnered with University of Coimbra to develop a first of its kind strategic partnership to research and create new knowledge on cannabis derived medical products.

Regional analysis

North America accounts for the largest market share and will continue to retain the leading position in the market due to increasing legalization of medical cannabis in independent states of the U.S., the liberalisation of government regulations regarding the acceptance of cannabidiol for pharmaceutical, wellness, and personal use are some of the major factors driving the growth of the region.
Asia Pacific market is anticipated to grow the fastest growth over the forecast period due to the setup of hemp manufacturing plants, in China. China is the largest hemp cultivator in Asia and cultivates nearly half of the world’s hemp production. The country also exports nearly 90% of its products to the U.S., Germany, U.K., Netherlands, and Japan.

Legal Marijuana Regional include U.S., Canada, Germany, Italy, Netherlands, Croatia, Poland, Czech Republic, Switzerland, Australia, Uruguay, Colombia, Mexico, Chile, Argentina, Israel.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Medicinal Cannabis Market
Chapter 5. Global Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (Kilo Tons) (USD Million)
5.1. Global Medicinal Cannabis Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. On-Premise
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Cloud-Based
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (Kilo Tons) (USD Million)
6.1. Medicinal Cannabis Share, By End User, 2015 - 2027 (USD Million)
6.1.1. SME (Small and Medium Enterprises)
6.1.1.1. Market Size and projections,2015 - 2027 (Kilo Tons) (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Large Enterprise
6.1.2.1. Market Size and projections,2015 – 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Medicinal Cannabis Market Overview, By Geography, 2015 - 2027 (Kilo Tons) (USD Million)
7.1. Medicinal Cannabis Market Share, By Geography, 2015 - 2027 (Kilo Tons) (USD Million)
7.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 8. North America Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (Kilo Tons) (USD Million)
8.1. North America Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.3. North America Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
8.1.4. North America Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Medicinal Cannabis Market Overview, By End User,2015 - 2027 (USD Million)
8.1.4.2. Canada Medicinal Cannabis Market Overview, 2015 - 2027 (Kilo Tons) (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (Kilo Tons) (USD Million)
8.1.4.2.2. Canada Medicinal Cannabis Market Overview, By Type, 2015 – 2027 (USD Million)
8.1.4.2.3. Canada Medicinal Cannabis Market Overview, By End User,2015 - 2027 (USD Million)
8.1.4.3. Mexico Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Medicinal Cannabis Market Overview, By End User,2015 - 2027 (USD Million)
Chapter 9. Europe Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (Kilo Tons) (USD Million)
9.1. Europe Medicinal Cannabis Market Overview, 2015 – 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (Kilo Tons) (USD Million)
9.1.2. Europe Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. Europe Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4. Europe Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.2.3. France Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.3.3. UK Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.4.3. Italy Medicinal Cannabis Market Overview, By End User 2015 - 2027 (USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.5.3. Spain Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.6.3. Rest of Europe Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 10. Asia Pacific Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.1.3. India Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.2.2. China Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.2.3. China Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.3.3. Japan Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.4.2. South Korea Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (Kilo Tons) (USD Million)
10.1.4.4.3. South Korea Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.5.3. Rest of Asia Pacific Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 12. South America Medicinal Cannabis Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Medicinal Cannabis Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. South America Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4. South America Medicinal Cannabis Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.4.1. Brazil
12.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.1.2. Brazil Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.1.3. Brazil Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4.2. Argentina
12.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.2.2. Argentina Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.2.3. Argentina Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4.3. Rest of South America
12.1.4.3.1. Market size and projections, 2015 – 2026
12.1.4.3.2. Rest of South America Medicinal Cannabis Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.3.3. Rest of South America Medicinal Cannabis Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Type development
Chapter 14. Key Vendor Analysis
14.1. Canopy Growth Corporation.
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Type Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Tilray.
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Type Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Aurora Cannabis
14.4. Tilray.
14.5. GW Pharmaceuticals.
14.6. The Green Organic Dutchman
14.7. Terra Tech
Chapter 15. Medicinal Cannabis Market Cost Analysis
15.1. Medicinal Cannabis Market Key Raw Materials Analysis
15.1.1. Key Raw Materials
15.1.2. Price Trend of Key Raw Materials
15.1.3. Key Suppliers of Raw Materials
15.1.4. Market Concentration Rate of Raw Materials
15.2. Proportion of Wing Cost Structure
15.2.1. Raw Materials
15.2.2. Labor Cost
15.2.3. Wing Expenses
15.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 16. Chain, Sourcing Strategy and Downstream Buyers
16.1. Medicinal Cannabis Market Chain Analysis
16.2. Upstream Raw Materials Sourcing
16.3. Raw Materials Sources of Medicinal Cannabis Market Major Manufacturers in 2019
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Large Enterprise
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Type Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Type Progress in Related Industry
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Medicinal Cannabis Market share, by Type, 2020 & 2027 (%)
10. Global Medicinal Cannabis Market share, by Type 2020 & 2027 (USD Million)
11. Global Medicinal Cannabis Market share, by End User, 2020 & 2027 (%)
12. Global Medicinal Cannabis market share, by SME (Small and Medium Enterprises), by End User, 2020 & 2027 (USD Million)
13. Global Medicinal Cannabis market share, by Large Enterprise, by End User, 2020 & 2027 (USD Million)
14. Global Medicinal Cannabis market share, by region, 2020 - 2027(%)
15. Global Medicinal Cannabis market share, by region, 2019 - 2027(USD Million)
16. North America Medicinal Cannabis Market, 2020 - 2027(USD Million)
17. North America Medicinal Cannabis Market share, by Countries, 2020 & 2027 (%)
18. U.S. Medicinal Cannabis Market, 2020 - 2027(USD Million)
19. Canada Medicinal Cannabis Market, 2020 - 2027(USD Million)
20. Europe Medicinal Cannabis Market, 2020 - 2027(USD Million)
21. Europe Medicinal Cannabis Market share, by Countries, 2020 & 2027 (%)
22. Spain Medicinal Cannabis Market, 2020 - 2027(USD Million)
23. UK Medicinal Cannabis Market, 2020 - 2027(USD Million)
24. Italy Medicinal Cannabis Market, 2020 - 2027(USD Million)
25. Germany Medicinal Cannabis Market, 2020 - 2027(USD Million)
26. France Medicinal Cannabis Market, 2020 - 2027(USD Million)
27. Rest of Europe Medicinal Cannabis Market, 2020 - 2027(USD Million)
28. Asia-Pacific Medicinal Cannabis Market, 2020 - 2027(USD Million)
29. Asia-Pacific Medicinal Cannabis Market share, by Countries, 2020 & 2027 (%) China Medicinal Cannabis Market, 2020 - 2027(USD Million)
30. India Medicinal Cannabis Market, 2020 - 2027(USD Million)
31. Australia Medicinal Cannabis Market, 2020 - 2027(USD Million)
32. Japan Medicinal Cannabis Market, 2020 - 2027(USD Million)
33. Rest of Asia-Pacific Medicinal Cannabis Market, 2020 - 2027(USD Million)
34. Middle East & Africa Medicinal Cannabis Market, 2020 - 2027(USD Million)
35. Middle East & Africa Medicinal Cannabis Market share, by Countries, 2020 & 2027 (%)
36. GCC Medicinal Cannabis Market, 2020 - 2027(USD Million)
37. South Africa Medicinal Cannabis Market, 2020 - 2027(USD Million)
38. Rest Of Middle East & Africa Medicinal Cannabis Market, 2020 - 2027(USD Million)
39. South America Medicinal Cannabis Market, 2020 - 2027(USD Million)
40. Brazil Medicinal Cannabis Market, 2020 - 2027(USD Million)
41. Mexico Medicinal Cannabis Market, 2020 - 2027(USD Million)
42. Argentina Medicinal Cannabis Market, 2020 - 2027(USD Million)
43. Rest Of South America Medicinal Cannabis Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Medicinal Cannabis Market, 2020-2027 (USD Million)
4. Medicinal Cannabis requirement, by country, 2020-2027, (USD Million)
5. North America Medicinal Cannabis Market, by Type, 2020-2027 (USD Million)
6. North America Medicinal Cannabis Market, by End User, 2020-2027 (USD Million)
7. Europe Medicinal Cannabis Market, by Type, 2020-2027 (USD Million)
8. Europe Medicinal Cannabis Market, by End User, 2020-2027 (USD Million)
9. Asia Pacific Medicinal Cannabis Market, by Type, 2020-2027 (USD Million)
10. Asia Pacific Medicinal Cannabis Market, by End User, 2020-2027 (USD Million)
11. Middle East & Africa Medicinal Cannabis Market, by Type, 2020-2027 (USD Million)
12. Middle East & Africa Medicinal Cannabis Market, by End User, 2020-2027 (USD Million)
13. South America Medicinal Cannabis Market, by Type, 2020-2027 (USD Million)
14. South America Medicinal Cannabis Market, by End User, 2020-2027 (USD Million)
15. Global Medicinal Cannabis Market, Company Market Share, 2018 (%)
16. CANOPY GROWTH CORPORATION : Product Benchmarking
17. CANOPY GROWTH CORPORATION : Financial Performance
18. Tilray: Product Benchmarking
19. Tilray: Financial Performance
20. Aurora Cannabis: Product Benchmarking
21. Aurora Cannabis: Financial Performance
22. GW Pharmaceuticals: Product Benchmarking
23. GW Pharmaceuticals: Financial Performance
24. The Green Organic Dutchman: Product Benchmarking
25. The Green Organic Dutchman: Financial Performance

The Leading Key Players in Medicinal Cannabis Market

BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis Inc.
Canopy Growth Corporation
Insys Therapeutics Inc.
Aphria Inc.
MGC Pharmaceuticals Limited
GW Pharmaceuticals plc.
Medical Marijuana Inc.